Epinephrine Autoinjector Market size to grow by USD 2.44 billion from 2023 to 2028, North America to account for 46% of market growth- Technavio

How is the Epinephrine Autoinjector Market expected to grow in the next five years?

NEW YORK, Jan. 7, 2024 /PRNewswire/ — The epinephrine autoinjector market size is expected to grow by USD 2.44 billion from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 10.59% during the forecast period, according to Technavio Research.

How is the Epinephrine Autoinjector Market segmented?

The market is segmented by type (0.30gm, 0.15gm, and 0.50gm), end-user (hospitals, clinics, and home care), and geography (North America, Europe, Asia, and the Rest of the World (ROW)).

Which region is expected to significantly contribute to the Epinephrine autoinjector Market?

North America is estimated to contribute 46% to the growth of the global market during the forecast period. The US and Canada are the key contributors to the market in the region. The Viatriss monopolist position on the booming US market has been facilitated by not having received approval from the FDA or strict Food and Drug Administration rules which did not even consider any alternate epinephrine autoinjector in comparison to Viatriss EpiPen.

This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a Free PDF Sample Report

Who are the key players operating in the Epinephrine Autoinjector Market?

Adamis Pharmaceuticals Corp., ALK Abello AS, Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., BIOPROJET, Crossject, Halozyme Therapeutics Inc., Kaleo Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc.

Adamis Pharmaceuticals Corp. – The company offers epinephrine autoinjectors such as SYMJEPI 0.15mg, and SYMJEPI 0.3mg

To gain access to more company profiles available with Technavio, buy the report!

Epinephrine Autoinjector Market: Segmentation Analysis

The market share growth by the 0.30gm segment will be significant during the forecast period. The growth is expected in the epinephrine injection market by 0.30mg dosage due to rising volume sales of generic anaphylaxis autoinjectors.

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a Free PDF Sample Report

Epinephrine Autoinjector Market: Market Dynamics

What are the main growth drivers for the Epinephrine Autoinjector market?

Rise in awareness of anaphylaxis and availability of innovative epinephrine autoinjectorsRising innovations in marketing strategies by market playersIncreasing prevalence of allergies

The Epinephrine Autoinjector Market experiences notable growth due to increased awareness of anaphylaxis and innovative autoinjectors. This rise in Anaphylaxis Awareness drives demand for effective Anaphylaxis Treatment and Emergency Allergy Treatment solutions. Addressing autoimmune responses and adhering to the Anaphylaxis Protocol necessitates advancements in Allergic Response Management. User-friendly autoinjectors and stringent Epinephrine Safety Measures further catalyze market growth, emphasizing the critical role of accessibility and safety in managing severe allergic reactions.

Who can offer a comprehensive analysis of the current market trends in Epinephrine Autoinjector?

Technavio Analyzes that the Epinephrine Autoinjector Market is witnessing an emerging trend of frequent product launches influenced by government pressure on companies. This trend affects the landscape of EpiPen, Epinephrine Injection, and Adrenaline Autoinjector offerings. Innovations in Epinephrine Delivery, Administration, and Auto-Injector Devices signify the quest for EpiPen Alternatives, optimizing Epinephrine Dosage, Availability, and Storage. Government initiatives drive a dynamic market, shaping evolving Epinephrine Autoinjector Market Trends through continuous product enhancements and launches.

What are some of the challenges faced by the Epinephrine Autoinjector Market?

Challenges like product recall and regulatory issues significantly impede the growth of the Epinephrine Autoinjector Market. These hurdles impact critical areas such as Allergic Reactions, Severe Allergic Responses, and Anaphylactic Shock management. Issues in Food Allergy Management and the delivery of Allergy Relief Devices hinder efforts to address Life-Threatening Allergies. Ensuring Rapid Allergic Reaction Treatment via Portable Allergy Treatment solutions is constrained, affecting the availability of Allergy Emergency Kits and other essential Allergy Care Products, hampering overall Allergy Preparedness.

Identify key trends, drivers, and challenges in the market. Download a sample to gain access to this information.

Related Reports:

The autoinjectors market size is estimated to grow at a CAGR of 25.14% between 2022 and 2027. The autoinjectors market size is forecast to increase by USD 134,014.58 million. 

The Pre-filled syringes market size is forecast to increase by USD 3.512 billion between 2022 and 2027, accelerating at a CAGR of 8.93%. 

What are the key data covered in this epinephrine autoinjector market report?

CAGR of the market during the forecast periodDetailed information on factors that will drive the growth of the epinephrine autoinjector market between 2023 and 2028.Precise estimation of the epinephrine autoinjector market size and its contribution to the market in focus on the parent marketAccurate predictions about upcoming trends and changes in consumer behaviorGrowth of the epinephrine autoinjector market across North America, Europe, Asia, and ROWA thorough analysis of the market’s competitive landscape and detailed information about companiesComprehensive analysis of factors that will challenge the growth of epinephrine autoinjector market companies.

ToC:

Executive Summary

Market Landscape

Market Sizing

Historic Market Sizes

Five Forces Analysis

Market Segmentation by Type

Market Segmentation by End-user

Market Segmentation by Geography

Customer Landscape

Geographic Landscape

Drivers, Challenges, & Trends

Company Landscape

Company Analysis

Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/epinephrine-autoinjector-market-size-to-grow-by-usd-2-44-billion-from-2023-to-2028–north-america-to-account-for-46-of-market-growth–technavio-302027156.html

SOURCE Technavio